| Dr Matthew Ryan Deluhery, MD | |
|
725 American Ave, Emergency Medical Associates Of Waukesha, Waukesha, WI 53188-5031 | |
| (262) 928-1000 | |
| (262) 928-5697 |
| Full Name | Dr Matthew Ryan Deluhery |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 725 American Ave, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477725547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 53619-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waukesha Memorial Hospital | Waukesha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medical Associates Llp | 0648242065 | 15 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Entity Name | Emergency Medicine Specialists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568413524 PECOS PAC ID: 8729975461 Enrollment ID: O20040228000032 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Entity Name | Emergency Medical Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861483190 PECOS PAC ID: 0648242065 Enrollment ID: O20040806000968 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Entity Name | Lake Country Emergency Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720060585 PECOS PAC ID: 4385607555 Enrollment ID: O20041109000212 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Ryan Deluhery, MD 725 American Ave, Emergency Medical Associates Of Waukesha, Waukesha, WI 53188-5031 Ph: (262) 928-2475 | Dr Matthew Ryan Deluhery, MD 725 American Ave, Emergency Medical Associates Of Waukesha, Waukesha, WI 53188-5031 Ph: (262) 928-1000 |
News Archive
Researchers in the United States have conducted a study showing the efficacy of the Moderna and Pfizer-BioNTech vaccines at eliciting a robust T cell response against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
Scientists have discovered that a molecule called DJ-1 is likely to be involved in the generation of human tumors through negative regulation of the well-known tumor suppressor, PTEN. The research, published in the March issue of Cancer Cell, has important implications for determining the prognosis of some human cancers, and may prove to be a suitable target for cancer therapy.
› Verified 2 days ago
Steven K Kulick, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Dr. Jennifer Quick Grieve, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 | |
Keith L Mausner, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Dr. James Mateer, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Qurisha Monique Boyd, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2411 Springdale Rd Apt 5b, Waukesha, WI 53186 Phone: 262-888-2305 | |
Timothy J Helz, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 | |
Brian L Huckstorf, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 725 American Ave, Suite 5, Waukesha, WI 53188 Phone: 262-928-2475 Fax: 262-928-5697 |